This fact establishes a positive point regarding the therapy of SCA, since Hb‐AS individuals are potential bone marrow donors whose transplantation is considered the only method of curative treatment to the disease. The gene discussed is GSTM1; the disease is autosomal dominant cerebellar ataxia.